AVENUE THERAPEUTICS, INC. (ATXI)
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Address
1111 KANE CONCOURSE
BAY HARBOR ISLANDS, FL 33154
Founded
2015
Number of Employees
3
Website
http://www.avenuetx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)